Balanced Salt Solution Versus Normal Saline in Resuscitation of Pediatric Sepsis: A Randomized, Controlled Trial

Sirawut Trepatchayakorn1, Manee Sakunpunphuk2, Rujipat Samransamruajkit3

  • 1Division of Pediatric Critical Care, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Rd, Pathum Wan, Bangkok, 10330, Thailand. sirawut.t@chula.ac.th.

Insights

Pediatric sepsis resuscitation with normal saline solution (NSS), Ringer lactate solution (RLS), or Sterofundin showed no significant differences in complications. However, a large dose of RLS was linked to reduced urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels.

Area of Science:

  • Pediatric critical care medicine
  • Resuscitation science
  • Fluid therapy

Background:

  • Current evidence on crystalloid fluid resuscitation in adult sepsis is extensive, yet data specific to pediatric populations remains limited.
  • Understanding the impact of different crystalloid solutions on pediatric sepsis resuscitation outcomes is crucial for clinical practice.

Purpose of the Study:

  • To compare the resuscitation outcomes of pediatric sepsis patients treated with normal saline solution (NSS), Ringer lactate solution (RLS), or Sterofundin.
  • To investigate the association between crystalloid type and complications in pediatric sepsis resuscitation.

Main Methods:

  • A randomized trial involving 42 pediatric sepsis patients requiring fluid bolus therapy.
  • Patients were assigned to receive either NSS, RLS, or Sterofundin.
  • Outcomes, including complications and urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels, were assessed post-fluid bolus.

Main Results:

  • No significant differences in complications were observed among the three crystalloid groups after fluid bolus.
  • Patients in the RLS group who received a large fluid dose demonstrated a significant reduction in uNGAL levels.
  • This suggests a potential benefit of RLS in reducing a specific biomarker of kidney injury in pediatric sepsis.

Conclusions:

  • Fluid bolus therapy with NSS, RLS, or Sterofundin did not lead to different overall resuscitation outcomes in pediatric sepsis.
  • Higher doses of RLS may be associated with a greater reduction in uNGAL levels compared to other crystalloids, indicating a potential role in mitigating kidney stress.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
70
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
46